Since RANTES is upregulated in the colonic mucosa of UC patients22,23, it is plausible that the downregulation of RANTES upon uPA deletion/inhibition reduces the recruitment of leukocytes into the colitis tissue, and thereby ameliorates colitis in UC. The gene discussed is CCL5; the disease is colitis.